Journal article
Pustular psoriasis of pregnancy: current perspectives
International journal of women's health, v 10, pp 109-115
26 Feb 2018
PMID: 29520163
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Pustular psoriasis of pregnancy (PPP) is a life-threatening condition for both the pregnant mother and fetus, and must be efficiently and accurately diagnosed and treated. This condition has historically been classified as a unique, separate dermatosis of pregnancy. However, current opinion and data suggest that it may be a variant of generalized pustular psoriasis. PPP typically occurs in the third trimester and is characterized by widespread coalescent pustules, desquamation, and systemic symptoms. Clinical features and histopathologic evaluation aid in diagnosis. Treatments during pregnancy include high-dose corticosteroids, cyclosporine, narrow-band ultraviolet B radiation, infliximab, granulocyte and monocyte adsorptive apheresis, and systemic antibiotics. Both the mother and fetus should be closely monitored with appropriate laboratory studies for the duration of the pregnancy and postpartum.
Metrics
Details
- Title
- Pustular psoriasis of pregnancy: current perspectives
- Creators
- Megha K Trivedi - University of California, San FranciscoAlexandra R Vaughn - Drexel UniversityJenny E Murase - University of California, San Francisco
- Publication Details
- International journal of women's health, v 10, pp 109-115
- Publisher
- Dove Medical Press
- Resource Type
- Journal article
- Language
- English
- Web of Science ID
- WOS:000426500500001
- Scopus ID
- 2-s2.0-85046694391
- Other Identifier
- 991019357635104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Obstetrics & Gynecology